long-acting RIPK2 degrader (SC admin.)

in vivo degradation of RIPK2 over 60 days

IAP binder linked to RIPK2 binder

Journal of Medicinal Chemistry

GlaxoSmithKline, Stevenage, UK

compound 20

The GSK RIPK2 PROTAC, “compound 20”, demonstrates in vivo degradation of RIPK2 over 60 days after a single compound dose when administered SC in slow-release PLGA microparticles. This degrader…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: